140 related articles for article (PubMed ID: 23532895)
1. Exogenous SPARC suppresses proliferation and migration of prostate cancer by interacting with integrin β1.
Shin M; Mizokami A; Kim J; Ofude M; Konaka H; Kadono Y; Kitagawa Y; Miwa S; Kumaki M; Keller ET; Namiki M
Prostate; 2013 Aug; 73(11):1159-70. PubMed ID: 23532895
[TBL] [Abstract][Full Text] [Related]
2. Heterogenous induction of carcinoma-associated fibroblast-like differentiation in normal human prostatic fibroblasts by co-culturing with prostate cancer cells.
Ishii K; Mizokami A; Tsunoda T; Iguchi K; Kato M; Hori Y; Arima K; Namiki M; Sugimura Y
J Cell Biochem; 2011 Dec; 112(12):3604-11. PubMed ID: 21809373
[TBL] [Abstract][Full Text] [Related]
3. Osteoblasts-derived BMP-2 enhances the motility of prostate cancer cells via activation of integrins.
Lai TH; Fong YC; Fu WM; Yang RS; Tang CH
Prostate; 2008 Sep; 68(12):1341-53. PubMed ID: 18512729
[TBL] [Abstract][Full Text] [Related]
4. [Role of hepatocyte growth factor in invasion of prostate cancer cell lines through tumor-stromal interaction].
Nishimura K; Takada S; Miura H; Tsujimura A; Kitamura M; Nonomura N; Matsumiya K; Okuyama A
Hinyokika Kiyo; 2000 Oct; 46(10):769-74. PubMed ID: 11215208
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer stromal cells and LNCaP cells coordinately activate the androgen receptor through synthesis of testosterone and dihydrotestosterone from dehydroepiandrosterone.
Mizokami A; Koh E; Izumi K; Narimoto K; Takeda M; Honma S; Dai J; Keller ET; Namiki M
Endocr Relat Cancer; 2009 Dec; 16(4):1139-55. PubMed ID: 19608712
[TBL] [Abstract][Full Text] [Related]
6. Active estrogen synthesis and its function in prostate cancer-derived stromal cells.
Machioka K; Mizokami A; Yamaguchi Y; Izumi K; Hayashi S; Namiki M
Anticancer Res; 2015 Jan; 35(1):221-7. PubMed ID: 25550554
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta1 modulates tumor-stromal cell interactions of prostate cancer through insulin-like growth factor-I.
Kawada M; Inoue H; Arakawa M; Ikeda D
Anticancer Res; 2008; 28(2A):721-30. PubMed ID: 18507013
[TBL] [Abstract][Full Text] [Related]
8. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
Izumi K; Mizokami A; Li YQ; Narimoto K; Sugimoto K; Kadono Y; Kitagawa Y; Konaka H; Koh E; Keller ET; Namiki M
Prostate; 2009 Aug; 69(11):1222-34. PubMed ID: 19434660
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor I secreted from prostate stromal cells mediates tumor-stromal cell interactions of prostate cancer.
Kawada M; Inoue H; Masuda T; Ikeda D
Cancer Res; 2006 Apr; 66(8):4419-25. PubMed ID: 16618768
[TBL] [Abstract][Full Text] [Related]
10. Phthoxazolin A inhibits prostate cancer growth by modulating tumor-stromal cell interactions.
Kawada M; Inoue H; Usami I; Ikeda D
Cancer Sci; 2009 Jan; 100(1):150-7. PubMed ID: 19018764
[TBL] [Abstract][Full Text] [Related]
11. CCR2 expression correlates with prostate cancer progression.
Lu Y; Cai Z; Xiao G; Liu Y; Keller ET; Yao Z; Zhang J
J Cell Biochem; 2007 Jun; 101(3):676-85. PubMed ID: 17216598
[TBL] [Abstract][Full Text] [Related]
12. Prostate stromal cell-derived hepatocyte growth factor induces invasion of prostate cancer cell line DU145 through tumor-stromal interaction.
Nishimura K; Kitamura M; Miura H; Nonomura N; Takada S; Takahara S; Matsumoto K; Nakamura T; Matsumiya K
Prostate; 1999 Nov; 41(3):145-53. PubMed ID: 10517872
[TBL] [Abstract][Full Text] [Related]
13. The search for secreted proteins in prostate cancer by the Escherichia coli ampicillin secretion trap: expression of NBL1 is highly restricted to the prostate and is related to cancer progression.
Hayashi T; Sentani K; Oue N; Ohara S; Teishima J; Anami K; Sakamoto N; Matsubara A; Yasui W
Pathobiology; 2013; 80(2):60-9. PubMed ID: 22948749
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of DHCR24/seladin-1 impairs cellular homeostasis in prostate cancer.
Battista MC; Guimond MO; Roberge C; Doueik AA; Fazli L; Gleave M; Sabbagh R; Gallo-Payet N
Prostate; 2010 Jun; 70(9):921-33. PubMed ID: 20166102
[TBL] [Abstract][Full Text] [Related]
15. In prostate cancer C/EBPalpha promotes cell growth by the loss of interactions with CDK2, CDK4, and E2F and by activation of AKT.
Yin H; Lowery M; Glass J
Prostate; 2009 Jun; 69(9):1001-16. PubMed ID: 19347879
[TBL] [Abstract][Full Text] [Related]
16. Naftopidil, a selective {alpha}1-adrenoceptor antagonist, suppresses human prostate tumor growth by altering interactions between tumor cells and stroma.
Hori Y; Ishii K; Kanda H; Iwamoto Y; Nishikawa K; Soga N; Kise H; Arima K; Sugimura Y
Cancer Prev Res (Phila); 2011 Jan; 4(1):87-96. PubMed ID: 21205739
[TBL] [Abstract][Full Text] [Related]
17. Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast transdifferentiation.
Untergasser G; Gander R; Lilg C; Lepperdinger G; Plas E; Berger P
Mech Ageing Dev; 2005 Jan; 126(1):59-69. PubMed ID: 15610763
[TBL] [Abstract][Full Text] [Related]
18. SPARC is associated with gastric cancer progression and poor survival of patients.
Zhao ZS; Wang YY; Chu YQ; Ye ZY; Tao HQ
Clin Cancer Res; 2010 Jan; 16(1):260-8. PubMed ID: 20028745
[TBL] [Abstract][Full Text] [Related]
19. Versican accumulation in human prostatic fibroblast cultures is enhanced by prostate cancer cell-derived transforming growth factor beta1.
Sakko AJ; Ricciardelli C; Mayne K; Tilley WD; Lebaron RG; Horsfall DJ
Cancer Res; 2001 Feb; 61(3):926-30. PubMed ID: 11221884
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of calcium/calmodulin-dependent protein kinase kinase 2 by androgen deprivation induces castration-resistant prostate cancer.
Shima T; Mizokami A; Miyagi T; Kawai K; Izumi K; Kumaki M; Ofude M; Zhang J; Keller ET; Namiki M
Prostate; 2012 Dec; 72(16):1789-801. PubMed ID: 22549914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
